An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia

✍ Scribed by Montillo, M.; Tedeschi, A.; Petrizzi, V. B.; Ricci, F.; Crugnola, M.; Spriano, M.; Spedini, P.; Ilariucci, F.; Uziel, L.; Attolico, I.; Vismara, E.; De Blasio, A.; Zaccaria, A.; Morra, E.

• Book ID: 121711767
• Publisher: American Society of Hematology
• Year: 2011
• Tongue: English
• Weight: 147 KB
• Volume: 118
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2011-05-351833